Bukwang Pharm (003000)

Seoul

Currency in KRW

4,305

+105(+2.50%)

Delayed Data·01:20:38

Fair Value

Unlock Value

Day's Range

4,285

4,820

52 wk Range

3,235

9,890

003000 Income Statement

Assess the Bukwang Pharm income statement, providing a detailed view of the company’s financial performance across activities. This statement outlines key financial figures such as revenue, expenses, operating income, and net income. Assess the 003000 net worth.

Period Ending:

2016

31/12

2017

31/12

2018

31/12

2019

31/12

2020

31/12

2021

31/12

2022

31/12

2023

31/12

2024

31/12

2025

31/12

Total Revenues

aa.aa

182,491.22

190,909.36

125,928.24

160,086.87

200,714.18

Total Revenues Growth

aa.aa

+7.56%

+4.61%

-34.04%

+27.13%

+25.38%

Cost Of Revenues

aa.aa

106,941.63

111,762.6

79,012.32

86,022.57

109,185.97

Gross Profit

aa.aa

75,549.59

79,146.77

46,915.92

74,064.3

91,528.21

Gross Profit Growth

aa.aa

+5.9%

+4.76%

-40.72%

+57.87%

+23.58%

Gross Profit Margin %

aa.aa

41.4%

41.46%

37.26%

46.27%

45.6%

Other Operating Expenses, Total

aa.aa

69,927.71

79,377.4

84,412.68

72,446.64

77,364.41

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	+3.88%	+13.51%	+6.34%	-14.18%	+6.79%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	22,464.64	24,274.42	34,551.21	23,430.64	19,401.4
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	45,170.48	52,698.48	46,377.14	45,411.09	55,622.86
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	1,317.25	1,345.2	2,078.39	2,225.27	470.86

Operating Income

aa.aa

5,621.88

-230.64

-37,496.76

1,617.66

14,163.8

Operating Income Growth

aa.aa

+39.56%

-104.1%

-16,158.01%

+104.31%

+775.57%

EBIT Margin %

aa.aa

3.08%

-0.12%

-29.78%

1.01%

7.06%

Net Interest Expenses

aa.aa

-1,140.16

-320.33

-727.77

-2,070.85

815.55

Net Interest Expenses Growth

aa.aa

-465.06%

+71.91%

-127.2%

-184.55%

+139.38%

Interest Expense, Total

aa.aa

-1,408.31

-1,760.3

-3,807.57

-6,489.6

-3,895.03

Interest And Investment Income

aa.aa

268.16

1,439.98

3,079.81

4,418.75

4,710.58

Other Non Operating Expenses, Total

aa.aa

-1,004.97

33.31

-811.1

-1,476.93

-16.38

EBT, Excl. Unusual Items

aa.aa

3,476.76

-517.65

-39,035.63

-1,930.12

14,962.97

Gain (Loss) On Sale Of Assets

aa.aa

220.05

52.25

30.64

53.75

374.4

Other Unusual Items, Total

aa.aa

-916.4

-2,524.34

EBT, Incl. Unusual Items

aa.aa

3,787.33

-1,032.87

-39,569.39

-2,969.52

6,386.11

EBT, Incl. Unusual Items Growth

aa.aa

+145.63%

-127.27%

-3,731%

+92.5%

+315.06%

EBT, Incl. Unusual Items Margin

aa.aa

2.08%

-0.54%

-31.42%

-1.85%

3.18%

Income Tax Expense

aa.aa

6,584.13

3,215.8

-5,162.87

489.25

-6,046.97

Net Income to Company

aa.aa

-2,796.8

-4,248.68

-34,406.51

-3,458.76

12,433.08

Minority Interest

aa.aa

1,880.18

1,773.82

3,076.85

817.44

124.48

Net Income

aa.aa

-916.62

-2,474.85

-31,329.66

-2,641.33

12,557.56

Net Income Growth

aa.aa

+87.27%

-170%

-1,165.92%

+91.57%

+575.43%

Net Income Margin %

aa.aa

-0.5%

-1.3%

-24.88%

-1.65%

6.26%

Preferred Dividend and Other Adjustments

aa.aa

Net Income to Common Excl. Extra Items

aa.aa

-916.62

-2,474.85

-31,329.66

-2,641.33

12,557.56

Basic EPS - Continuing Operations

aa.aa

-13.39

-36.15

-457.67

-39

152.01

Basic EPS - Continuing Operations Growth

aa.aa

+87.24%

-170.02%

-1,165.92%

+91.48%

+489.78%

Diluted EPS - Continuing Operations

aa.aa

-13.39

-36.15

-458

-39

152.01

Diluted EPS - Continuing Operations Growth

aa.aa

+87.25%

-170.02%

-1,166.83%

+91.48%

+489.78%

Basic Weighted Average Shares Outstanding

aa.aa

68.46

68.45

67.73

82.61

Diluted Weighted Average Shares Outstanding

aa.aa

68.46

68.45

67.73

82.61

Dividend Per Share

aa.aa

Dividend Per Share Growth

aa.aa

EBITDA

aa.aa

10,464.64

4,885.89

-33,204.32

5,723.69

19,652.48

EBITDA Growth

aa.aa

+2.74%

-53.31%

-779.6%

+117.24%

+243.35%

EBITDA Margin %

aa.aa

5.73%

2.56%

-26.37%

3.58%

9.79%

EBIT

aa.aa

5,621.88

-230.64

-37,496.76

1,617.66

14,163.8

* In Millions of KRW (except for per share items)

FAQ

What was Bukwang Pharm’s revenue at year end?

At the end of the last reported fiscal year, Bukwang Pharm (003000) recorded total revenue of 200,714 million KRW.

How much revenue did Bukwang Pharm report in the most recent quarter?

In its most recent quarterly earnings report, Bukwang Pharm posted revenue of 47,776 million KRW.

What was Bukwang Pharm’s net income for the year?

For the full year, Bukwang Pharm reported net income of 12,558 million KRW.

How much net income did Bukwang Pharm post in the last quarter?

In the most recent quarter, Bukwang Pharm (003000) posted net income of 1,177 million KRW.

What was Bukwang Pharm’s gross profit for the year?

Gross profit for the year was reported at 91,528 million KRW.

How much gross profit did Bukwang Pharm generate last quarter?

Bukwang Pharm recorded gross profit of 18,949 million KRW in its latest quarterly report.

What was Bukwang Pharm’s annual operating income?

For the full year, Bukwang Pharm (003000) reported operating income of 14,164 million KRW.

What was Bukwang Pharm’s operating income last quarter?

Quarterly operating income was 1,104 million KRW.

What was Bukwang Pharm’s quarterly EBITDA?

In the latest quarter, EBITDA was reported at 2,477 million KRW.

What was the quarter-over-quarter change in EBITDA for Bukwang Pharm?

EBITDA changed by -74% million KRW compared to the last quarter.

What is Bukwang Pharm’s most recent gross profit margin?

The latest reported gross profit margin for Bukwang Pharm (003000) is 40% million KRW.

What is Bukwang Pharm’s most recent net income margin?

Net income margin based on recent financials is 2% million KRW.

What is Bukwang Pharm’s most recent EBIT margin?

Bukwang Pharm reported an EBIT margin of 2% million KRW based on current figures.

How did Bukwang Pharm’s revenue change compared to the previous quarter?

Revenue changed by -24% million KRW compared to the prior quarter.

What was the quarter-over-quarter change in gross profit for Bukwang Pharm?

In the latest quarter, gross profit changed by -42% million KRW from the previous quarter.

S&P/TSX

36,401.79

+33.86

+0.09%

S&P/TSX 60

2,136.14

-7.72

-0.36%

US 30

53,488.80

+25.7

+0.05%

US 500

7,718.50

+10.1

+0.13%

S&P 500 VIX

14.89

-0.95

-6.00%

DAX

26,091.33

-37.03

-0.14%

Dollar Index

98.803

+0.072

+0.07%

Market Movers

Name	Last	Chg. %	Vol.
RBC	286.92	-3.15%	4.85M
Canadian Natural	68.48	-0.74%	15.37M
Enbridge	69.49	-2.69%	14.71M
Manulife Financial	60.06	-1.96%	15.65M
Toronto Dominion Bank	163.64	-3.53%	4.93M
Bank of Montreal	242.62	-4.44%	3.02M
Suncor Energy	93.30	-0.97%	6.62M

Name	Last	Chg. %	Vol.
Lanebury Growth Capital	0.15	+200.00%	1.00K
Beckett’s	0.01	+200.00%	5.00K
Green Scientific Labs Holdings	0.06	+120.00%	15.00K
Lithos Energy	0.21	+110.00%	500.00
ePlay Digital	0.010	+100.00%	7.00K
Digital Asset Tech	0.01	+100.00%	15.50K
Martello Tech	0.0100	+100.00%	14.00K

Name	Last	Chg. %	Vol.
Pharmadrug	0.01	-100.00%	277.00K
Patriot Gold	0.01	-87.50%	1.00K
Nepra Foods	0.18	-52.05%	73.40K
Nepra Foods	0.18	-50.68%	73.40K
Playground Ventures	0.010	-50.00%	1.00K
EnviroMetal Technologies	0.01	-50.00%	34.06K
Pharmadrug	0.0050	-50.00%	277.00K

Trending Stocks

Name	Last	Chg. %	Vol.
Celestica Inc.	416.59	-3.56%	701.99K
Toronto Dominion Bank	163.64	-3.53%	4.93M
Keel Infra	4.47	+1.13%	6.66M
Canadian Imperial Bank	162.93	-3.69%	3.17M
Bank of Montreal	242.62	-4.44%	3.02M

Most Undervalued Stocks

Name	Last	Upside	Fair Value
A Aaaaaaaaaaaaaa A	130.35	+49.52%	194.90
Aaaaaaaaa	1.4500	+47.85%	2.1438
Aaaaaaa Aaaaa Aa A	29.64	+44.36%	42.79
Aaaaaaa	17.18	+43.90%	24.72
Aaaaaaaa	103.51	+43.19%	148.22
Aaaa Aaaaaaa Aaa	33.87	+41.52%	47.93
Aaaaa Aaa	5.54	+39.80%	7.74

Name	Last	Upside	Fair Value
A Aaaaaaaaaaaaaa A	130.35	+49.52%	194.90
Aaaaaaaaa	1.4500	+47.85%	2.1438
Aaaaaaa Aaaaa Aa A	29.64	+44.36%	42.79
Aaaaaaa	17.18	+43.90%	24.72
Aaaaaaaa	103.51	+43.19%	148.22
Aaaa Aaaaaaa Aaa	33.87	+41.52%	47.93
Aaaaa Aaa	5.54	+39.80%	7.74

See full list

Install Our AppScan QR code to install app

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Popular Searches

Please try another search

Bukwang Pharm (003000)

003000 Income Statement

FAQ

What was Bukwang Pharm’s revenue at year end?

How much revenue did Bukwang Pharm report in the most recent quarter?

What was Bukwang Pharm’s net income for the year?

How much net income did Bukwang Pharm post in the last quarter?

What was Bukwang Pharm’s gross profit for the year?

How much gross profit did Bukwang Pharm generate last quarter?

What was Bukwang Pharm’s annual operating income?

What was Bukwang Pharm’s operating income last quarter?

What was Bukwang Pharm’s quarterly EBITDA?

What was the quarter-over-quarter change in EBITDA for Bukwang Pharm?

What is Bukwang Pharm’s most recent gross profit margin?

What is Bukwang Pharm’s most recent net income margin?

What is Bukwang Pharm’s most recent EBIT margin?

How did Bukwang Pharm’s revenue change compared to the previous quarter?

What was the quarter-over-quarter change in gross profit for Bukwang Pharm?

Trending Stocks